Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Hutchison China Meditech Limited - news published 7 - readings 452

BACK

Hutchison China Meditech Limited

HUTCHMED Announces the Closing of the Global Offering and the Primary Listing in Hong Kong (Form 6-K)

HUTCHMED Announces the Closing of the Global Offering and the Primary Listing in Hong Kong Hong Kong, Shanghai, & Florham Park, NJ - Wednesday, June 30, 2021: HUTCHMED (China) Limited ('HUTCHMED' or the 'Company') (Nasdaq/AIM: HCM) today announces the listing of its ordinary shares ('Shares') on the Main Board of the Stock Exchange of Hong Kong Limited (the 'SEHK') under the s ...

30.06.2021

Hutchison China Meditech Limited

Blocklisting Six Monthly Return (Form 6-K)

Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Tuesday, June 29, 2021: HUTCHMED (China) Limited ('HUTCHMED' or the 'Company') (Nasdaq/AIM: HCM) announces the following blocklisting six monthly return: 1. Name of applicant: HUTCHMED (China) Limited 2. Name of scheme: (a) Share Option Scheme conditionally adopted by HUTCHMED in 2005 ('2005 HUTCHMED Sha ...

29.06.2021

Hutchison China Meditech Limited

Supplemental Prospectus (SEC Filing - 424B5)

TABLE OF CONTENTS Filed pursuant to Rule 424(b)(5) Registration No. 333-237574 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered(1) Proposed maximum offering price per share(2) Proposed maximum aggregate offering price(2) Amount of registration fee(3) Ordinar ...

25.06.2021

Hutchison China Meditech Limited

Material Event (Form 6-K)

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's 'home country'), or under the rules of the h ...

25.06.2021

Hutchison China Meditech Limited

Letter from PricewaterhouseCoopers to the Securities and Exchange Commission, dated June 21, 2021 (Form 6-K)

Exhibit 16.1 June 21, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by HUTCHMED (China) Limited (formerly known as Hutchison China MediTech Limited) (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 5 of Form F-3, as part of HUTCHMED ...

21.06.2021

Hutchison China Meditech Limited

Supplemental Prospectus (SEC Filing - 424B5)

TABLE OF CONTENTS This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, and we are not soliciting offers to buy these securities in any jurisdictio ...

21.06.2021

Hutchison China Meditech Limited

HUTCHMED (China) Limited (Form 6-K)

HUTCHMED (China) Limited Condensed Consolidated Balance Sheets as of December 31, 2020 and March 31, 2021 F-2 Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2020 and 2021 F-3 Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2020 and 2021 ...

21.06.2021

Hutchison China Meditech Limited - news published 7 - readings 452

Hutchison China Meditech Limited

HUTCHMED Announces the Closing of the Global Offering and the Primary Listing in Hong Kong (Form 6-K)

Hutchison China Meditech Limited

Blocklisting Six Monthly Return (Form 6-K)

Hutchison China Meditech Limited

Supplemental Prospectus (SEC Filing - 424B5)

Hutchison China Meditech Limited

Material Event (Form 6-K)

Hutchison China Meditech Limited

Letter from PricewaterhouseCoopers to the Securities and Exchange Commission, dated June 21, 2021 (Form 6-K)

Hutchison China Meditech Limited

Supplemental Prospectus (SEC Filing - 424B5)

Hutchison China Meditech Limited

HUTCHMED (China) Limited (Form 6-K)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member